By Ben Glickman
Sientra is exploring strategic alternatives and withdrawing its full-year guidance as the company faces softer demand for plastic surgery.
The Irvine, Calif.-based surgical aesthetics company said that its preliminary third-quarter results had been dented by softer markets and seasonal headwinds, which led to fewer augmentation and reconstruction cases in the quarter.
The company said it expects these headwinds to persist due to economic and geopolitical factors, so it is withdrawing its full-year guidance.
Sientra said it was exploring strategic alternatives with its advisers and financial partners. Business will continue as usual during the process.
The company said it was expecting revenue of $19.2 million to $19.7 million for the third quarter, down from $22.6 million a year ago. Analysts polled by FactSet expected sales of $24.3 million.
Write to Ben Glickman at ben.glickman@wsj.com